Nanjing University (NJU) and the Publications Division of the American Chemical Society (ACS) have signed a three-year memorandum of understanding (MOU) during a ceremony on August 16, 2022. This solidifies their shared interest in supporting researchers globally, which includes launching a new partner journal, Chemical & Biomedical Imaging. This journal is another collaboration in this partnership that focuses on delivering top science to the research community.
Chemical & Biomedical Imaging will be a peer-reviewed, open access journal devoted to the publication of cutting-edge research in all areas of chemical and biomedical imaging. This interdisciplinary field sits at the intersections of chemistry, physics, biology, materials, engineering and medicine. The journal will highlight the latest challenges of fundamental research and applications in this expansive field via articles, reviews, letters, technical notes, perspectives, and viewpoints.
The inaugural editor-in-chief of Chemical & Biomedical Imaging is Dr. Zijian Guo, of NJU. Guo is an academician of the Chinese Academy of Sciences. His research focuses on the chemical biology of metals and metallodrugs, of which a particular focus of his lab is on the design and application of fluorescent sensors for biological metals, such as zinc, copper, and iron.
Chemical & Biomedical Imaging will begin to accept submissions in late 2022.
Click here to read the original press release.
